Por: NBC 6 South Florida World October 19, 2022
Makena Federal health advisers have concluded that a drug intended to prevent premature births hasn't been shown to work, clearing the way for U.S. regulators to follow through on a long-delayed effort to get it off the market. The ’s advisory panel voted 14-1 Wednesday that the injectable drug Makena should be withdrawn, despite appeals from the manufacturer to keep it available pending additional research. The experts essentially agreed... + full article
Associated Press USA Science October 20, 2022
WASHINGTON (AP) — Federal health advisers have concluded that a drug intended to prevent premature births hasn’t been shown to work, clearing the way for U.S. regulators to follow through on a long-delayed effort to get it off the market.The Food and Drug Administration’s... + más
FDA panel backs removal of unproven pregnancy drug | WPLG Local 10
FDA panel backs removal of unproven pregnancy drug | 10 WBNS
WPLG Local 10 USA Health October 19, 2022
WASHINGTON – Federal health advisers have concluded that a drug intended to prevent premature births hasn't been shown to work, clearing the way for U.S. regulators to follow through on a long-delayed effort to get it off the market.The Food and Drug Administration’s... + más
FDA panel backs removal of unproven pregnancy drug | ABC News
CNBC USA Health October 19, 2022
An advisory panel to the Food and Drug Administration voted Wednesday to take a drug intended to prevent premature births off the market, saying that it remains doubtful that the drug works.The recommendation, in a 14-1 vote, from the agency's Obstetrics, Reproductive and... + más
ALS drug wins FDA approval despite questionable data | ABC News
10 WBNS USA Health October 19, 2022
WASHINGTON — Federal health advisers ruled Wednesday that a drug intended to prevent premature births doesn’t work, clearing the way for U.S. regulators to follow through on a long-delayed effort to get it off the market. The Food and Drug Administration’s advisory panel... + más
ABC News USA Health October 19, 2022
WASHINGTON -- Federal advisers have concluded that a drug intended to prevent premature births hasn't been shown to work, clearing the way for U.S. regulators to follow through on a long-delayed effort to get it off the market.The Food and Drug Administration’s advisory... + más
Time USA Health October 19, 2022
WASHINGTON — Federal health advisers have concluded that a drug intended to prevent premature births hasn’t been shown to work, clearing the way for U.S. regulators to follow through on a long-delayed effort to get it off the market. The Food and Drug Administration’s... + más
Portland Press Herald USA Health October 19, 2022
WASHINGTON — Federal health advisers have concluded that a drug intended to prevent premature births hasn’t been shown to work, clearing the way for U.S. regulators to follow through on a long-delayed effort to get it off the market. A panel of federal advisers says Makena,... + más
About iurex | Privacy Policy | Disclaimer |